Axsome Thera (AXSM)
$76.67 4.23 (5.23%)
19:59 EDT AXSM Stock Quote Delayed 30 Minutes
Previous Close $76.67
Market Cap 1.97B
PE Ratio -73.02
Volume (Avg. Vol.) 784,177
Day's Range 76.14 - 82.80
52-Week Range 13.64 - 109.94
Dividend & Yield N/A (N/A)
AXSM Stock Predictions, Articles, and Axsome Thera News
- From InvestorPlace
- From the Web
Amid the COVID-19 pandemic, the investing pros say that it’s still possible to unmask names poised to take off on an upward trajectory.
Axsome Therapeutics (AXSM) news for Monday about results from the company's Phase 3 Trial of AXS-05 has AXSM stock rocketing higher.
These 10 stocks, including SHOP stock, have been among the best stocks in the market over the past year. Where do they go from here?
No longer a penny stock, Axsome Therapeutics (AXSM) surged past $8 a share on news that its AXS-05 treatment affected a 17.2-point drop in patients on the Montgomery-Asbert Depression Rating Scale. But is it a buy?
Axsome Therapeutics (AXSM) stock was flying high on Monday following some good AXSM news about a recent Phase 2 drug trial.
From Market News Video
Investors in Equity Lifestyle Properties Inc (ELS) saw new options become available today, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ELS options chain for the new July 17th contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader